Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Pharmaceutical and Biomedical Analysis|February 1, 1994
Pharmaceutical application of LC-MS. 1--Characterization of a famotidine degradate in a package screening study by LC-APCI MSX Z Qin, D P Ip, K H Chang, et al.Journal of Pharmaceutical and Biomedical Analysis|August 1, 1994
Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatography with indirect UV detectionE W Tsai, S D Chamberlin, R J Forsyth, et al.Journal of Pharmaceutical and Biomedical Analysis|July 31, 1998
Determination of losartan and its degradates in COZAAR tablets by reversed-phase high-performance thin-layer chromatographyK E McCarthy, Q Wang, E W Tsai, et al.The Journal of Urology|August 1, 1988
Characterization of urinary keratin number 18 using a new assayP V Rossitto, R Chan, M A Strand, et al.Journal of Pharmaceutical Sciences|November 1, 1994
Use of supercritical fluid extraction for sample preparation of sustained-release felodipine tabletsA L Howard, M C Shah, D P Ip, et al.Antimicrobial Agents and Chemotherapy|November 1, 1981
Pharmacokinetics of ceftriaxone in humansI H Patel, S Chen, M Parsonnet, et al.Clinical Pharmacology and Therapeutics|October 1, 1976
N-desmethyldiazepam: a new metabolite of chlordiazepoxide in manR Dixon, M A Brooks, E Postma, et al.Pediatric Pulmonology|August 1, 1996
Anabolic effect of biosynthetic growth hormone in cystic fibrosis patientsC A Huseman, J L Colombo, M A Brooks, et al.Proceedings of the National Academy of Sciences of the United States of America|August 20, 1996
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 proteinJ L Macen, R S Garner, P Y Musy, et al.Journal of Structural Biology|April 6, 2011
Strategies for the structural analysis of multi-protein complexes: lessons from the 3D-Repertoire projectB Collinet, A Friberg, M A Brooks, et al.Pageof 7